Award-winning consulting firm Fact.MR’s recently published report on the global nizatidine market for the forecast period 2021-2031 expects an optimistic future outlook, projecting noteworthy growth for the said period. Growth is expected to be primarily fueled by extensive application in gastric disorder treatment. According to a study published by a group of researchers at the University of Gothenburg, nearly 40% of adults suffer from a functional gastrointestinal disorder in a 73,000 person, 33 country survey. Functional gastrointestinal disorders represent a series of chronic disorders in the gastrointestinal tract that often include severe symptoms such as heartburn, acid reflux, and dyspepsia in the upper gastrointestinal tract.
The market experienced hiccups in the recent past amid a series of product recalls by prominent manufacturers due to several compliance incompatibilities. However, these withdrawals have been overturned, reopening growth frontiers. For instance, in September 2020, Amneal Pharmaceuticals Inc. announced that its nizatidine oral solution 15 mg/ml was available for reorder across the U.S., meeting all FDA requirements.
For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=6217
Key Segments Covered
-
Type
- Nizatidine Capsules
- Nizatidine Tablets
- Other Nizatidine Types
-
Distribution Channel
- Nizatidine for Hospital Pharmacies
- Nizatidine for Retail Pharmacies
- Nizatidine for Online Pharmacies
Request more information about Report Methodology – https://www.factmr.com/connectus/sample?flag=RM&rep_id=6217
Key Takeaways from Market Study
- By type, nizatidine capsules of doses of 150 mg and 300 mg to remain most preferred
- Retail and online sales of nizatidine products to experience massive incline over coming years
- Resumption of regulatory approval grants to stimulate nizatidine sales across the U.S.
- India to attract significant investments, attributed to high domestic manufacturing capabilities of generic drugs
- China to generate high demand amid rising prevalence of gastric cancer and irritable bowel syndrome
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/6217
Key Questions Answered in Report
- Which are the most lucrative nizatidine markets?
- Which factors will impact the growth of nizatidine?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the nizatidine industry?
- What are the winning strategies of stakeholders in the market?
For More Insights-https://www.prnewswire.com/news-releases/push-to-talk-ptt-services-and-solution-to-concentrate-increasingly-in-government–defense-sectors-factmr-301271566.html
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
